Newborn Male Circumcision for Prevention of Sexually Transmitted Infections in the United States: A Systematic Review by Crossen, Eric
Newborn Male Circumcision for Prevention of Sexually Transmitted Infections in 
the United States: A Systematic Review 
By 
Eric Crossen 
A Master's Paper submitted to the faculty of 
the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for 
the degree of Master of Public Health in 





PURPOSE: To clarify whether circumcision of newborn males in the U.S. reduces the risk of 
sexually transmitted infections (STis) later in life. 
DATA SOURCES: I searched the MEDLINE database (1948 through July 2009), Cochrane 
Library, and EM BASE. Other relevant articles were located through hand searches of 
bibliographies. 
STUDY SELECTION: I reviewed the literature for systematic reviews, randomized-controlled 
trials, cohort studies, case-control studies, and cross-sectional studies conducted in the United 
States that compared the effect of newborn male circumcision versus no circumcision on the 
development of various STis among adolescents and adults, including: gonorrhea, chlamydia, 
syphilis, chancroid, HIV, HSV-2, HPV, hepatitis B and C. 
DATA EXTRACTION: I abstracted the relevant data from the included articles. 
DATA SYNTHESIS: I identified 13 relevant studies described in 12 articles. Studies examining 
the association between circumcision status and STis differed in the risk profile of their study 
populations. Study populations could be described as general male population, high-risk 
heterosexual males, or men who have sex with men (MSM). Two studies of the general male 
population found no association between circumcision status and an array of STis. Seven 
studies of high-risk heterosexual males had mixed results with no consistent findings suggesting 
protection against a particular STI. Some evidence from the four studies of MSM suggested a 
protective effect against HIV, although these results were inconsistent across all the studies. 
CONCLUSION: There is insufficient evidence to conclude whether newborn circumcision does 
or does not protect against STis among U.S. males. Overall, the quality of evidence was fair. 
High-quality prospective studies are needed to further assess the effects of circumcision 
especially in high-risk U.S. men. 
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INTRODUCTION AND BACKGROUND 
I. THE ISSUE OF CIRCUMCISION 
Circumcision of newborn males is a frequent practice in the United States. According to 
the National Center for Health Statistics, 57.4% of male newborn infants in the U.S. were 
circumcised during hospitalization in 2004. 1 Although male circumcision persists as one of the 
most common surgeries in the U.S. and the world, it remains the subject of scientific and social 
debate. Multiple factors fuel the controversy about whether newborn males should be 
circumcised, including research demonstrating potential medical benefits as well as concerns 
about surgical complications.2 Additionally, cultural influences including religion and other 
familial, societal, and community norms play important roles in determining whether male infants 
are circumcised. 
Frequently cited reasons for newborn circumcision include religious and social 
importance,2· 3 and health-promoting and preventive effects 4 In Judaism and Islam, 
circumcision is a significant life event for male infants and adolescent males, respectively. 3 
Social norms are an important factor even in the absence of religious influence, as a father's 
circumcision status strongly influences the decision to circumcise his newborn. 5 Male 
circumcision has also been reported to decrease the risk of infantile urinary tract infection 
(UTI),6 penile cancer,7·9 and some sexually transmitted infections (STis),10· 11 and HIV infection 
in endemic regions of Africa. 12 
Common arguments against routine male circumcision cite the potential for surgical 
complications, 6· 13· 14 desire to avoid inflicting pain upon the infant, 13 unethical imposition of 
elective surgery on the infant,4 and cost of the procedure. Complication rates for neonatal 
circumcision range from 0.2 to 3%,6· 13· 14 and most commonly involve bleeding or infection. 
Although physiologic indicators of pain, such as "increased heart rate, prolonged crying, and 
2 
decreases in oxygen tension", have been documented in infants during circumcision, studies 
show that local anesthesia substantially reduces this response 13 suggesting that pain can be 
managed effectively. Because newborns lack the capacity to make an informed choice about 
circumcision, some may argue that it is unethical to subject a child to a procedure that is 
unessential to the child's current health 4 However, in our society we have deemed it the 
parents' responsibility to determine if circumcision is in the child's best interest.4 Finally, the 
cost of circumcision varies widely among medical providers and settings, and is not covered by 
all Medicaid programs and many private insurance plans, 15 indicating the potential financial cost 
posed by circumcision. 
Both vehement supporters and speculative critics of circumcision can be highly vocal 
about their viewpoints, making circumcision a hotly contested issue. This debate will likely 
continue to evolve as scientific research sheds new light on the connection between 
circumcision and health. 
II. HISTORICAL, CULTURAL, AND GEOGRAPHICAL CONTEXT 
Origins of circumcision 
The origin of male circumcision is uncertain. Anthropologist Sir Grafton Elliot Smith 
hypothesized that the custom of circumcision began as early as 15,000 B.C in Egypt. 16 Physical 
evidence of circumcision is found in Egyptian mummies and is corroborated by ancient wall 
carvings at Egyptian tombs that depict the act of circumcision, dating the custom's genesis to at 
least 6,000 years ago2 The Egyptians may have practiced circumcision to promote hygiene 
and prevent schistosomiasis (infection with the blood fluke, Schistosoma hematobium). 17 
Although this evidence points toward Egypt and Eastern Africa as the point of origin, other 
historical accounts describe circumcision existing among Native Australians and Native 
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Americans at the time of their first contact with Europeans. 18 This suggests that the practice of 
circumcision may have developed independently at multiple sites across the globe. 
Historically, circumcision has not always been promoted as a health-related practice. In 
fact, circumcision may have initially been a symbol of conquest over others. In ancient Egypt, 
captives were circumcised to indicate their status as slaves.16 Biblical passages refer to David 
circumcising his defeated foes and presenting their foreskins to the King Saul as a dowry (1 
Samuel 18:25-27). Circumcision may also have significance at the time of harvest in some 
cultures or may simply serve as a marker of cultural identity like a tattoo or piercing. 16 
Ritual circumcision 
Regardless of circumcision's original purpose, the practice spread to multiple cultures 
worldwide and, in many instances, took on special religious importance. In some African 
cultures, males are circumcised at birth.16 Ritual circumcision also plays a significant role in 
both Judaism and Islam. Abraham is a principal figure in both Judaism and Islam and the 
central role of circumcision in these religions may stem from the biblical account of Abraham. In 
Genesis 17, God entreats Abraham to circumcise himself and his sons as an outward symbol of 
their covenant with God (Genesis 17: 13). 
In Judaism, circumcision (Brit!Bris mi/ah) is performed on the eighth day of a newborn 
male's life, signifying the newborn's entry into Jewish tradition. Although mothers may have 
performed the ritual originally, 16 the responsibility of circumcising newborn males eventually 
transferred to mohe/s. These trained ritual circumcisers possess both surgical skills as well as 
knowledge of Jewish tradition and law. They introduced specialized tools for circumcision and 
continue to practice ritual circumcision today. 19 
Circumcision is also highly prevalent in the Muslim world. Of all males who are 
circumcised worldwide, 68% are Muslim.14 Although ritual circumcision is not specifically 
mentioned in the Koran, its importance is documented in the Sunnah (the recorded teachings 
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and actions of the Prophet Mohammed, who according to tradition was born without a 
foreskin20) and the practice is strongly encouraged. For Muslims, circumcision (!ahara, or 
purification) represents a young male's introduction to the Islamic faith and is a sign of 
belonging20 Muslims may undergo circumcision as early as the first week of life or as late as 
puberty, with seven being the preferred age.20 There is no Islamic corollary to the Jewish mohel 
and males are typically circumcised in hospitals or clinics. 
From uncertain origins, the practice of circumcision became globally pervasive and the 
importance of ritual circumcision in various cultures and religions facilitated this spread. Yet not 
all circumcisions today are ritualistic. Some modern societies practice routine circumcision for 
non-religious reasons. Routine circumcision is influenced by and evolved alongside ritual 
circumcision; however, these practices have important differences (e.g. involvement of medical 
professionals, use of anesthesia) that underscore the need to examine routine circumcision as a 
distinct issue. 
Routine circumcision 
Up until the 191" century, no evidence exists to indicate that physicians extensively 
performed circumcision. 16 Early reports of circumcision in the medical literature demonstrate 
the procedure's role in treating phimosis, 16 but do not describe any preventive benefits. By the 
late 191" century, however, some physicians began endorsing circumcision as a life-extending 
procedure and as a cure for a variety of ailments ranging from paralysis to rectal prolapse to 
asthma 2 Another notable indication for circumcision during this period was excessive 
masturbation.21 The procedure gained widespread popularity by the early 201" century and 
countless physicians began recommending routine circumcision of newborn males. In the late 
20th century, many physicians began questioning whether circumcision was medically 
necessary and medical organizations in countries such as Australia and Canada actually 
recommended against routine circumcision.22· 23 Circumcision rates in these countries 
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subsequently declined, yet statements by the American Academy of Pediatrics in the 1970s that 
"there is no absolute medical indication for routine circumcision of the newborn," resulted in a 
more modest decline.2· 24 
Circumcision in the U.S. 
The World Health Organization estimates that 30% of males worldwide and 75% of U.S. 
males have been circumcised.14 Circumcision is much more common in the U.S. than in South 
America, Central America, and much of Asia 4 Among developed countries, circumcision is 
much more common in the U.S. than in Canada25 (about half of males are circumcised), 
Australia, and most of Europe. 
In the U.S., circumcision frequency has changed over time and also varies with 
geographic location, socioeconomic status, and racial/ethnic group. The annual incidence of 
male circumcision in the U.S. reached its peak at about 85% in 196526 The previous recorded 
low was 31% in 1932.26 In the past decade, annual circumcision incidence hovered around 
60%, with a recent low of 55% in 2003 and slight increase to 57% in 200427 
In the last fifteen years, there have been prominent regional differences in circumcision 
incidence. Hospital discharge data indicates that the highest incidence of circumcision has 
been in the North Central/Midwest region, where about 80% of newborn males were 
circumcised annually over the last decade and a half27 The Northeast and South regions 
maintained annual circumcision incidence between 60-70% during the early 1990s, but recently 
the incidence of circumcision in the South has dropped as low as 55% in 200627 Meanwhile, 
the Northeast continued to exceed the national average at about 64% in 2006. 27 The region 
with the lowest incidence of annual male circumcision is the West, with rates ranging from 31% 
in 2003 to 34% in 2006. 27 The annual incidence in the West has been consistently below the 
national average27 Of note, these figures underestimate the true incidence of newborn 
circumcision because they only account for those circumcised prior to hospital discharge. 
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Circumcision rates also vary according to families' access to care. Circumcision is more 
common among families with higher socioeconomic status26 This trend will likely continue as 
insurers, including Medicaid, drop coverage for newborn circumcision. 15 Additionally, data from 
the National Health and Social Life Survey suggest that whites are more likely to be circumcised 
in the U.S. (81 %) than several minority groups including blacks (65%) and Hispanics (54%)26 
Ill. WHY FOCUS ATTENTION ON CIRCUMCISION? 
A large proportion of the U.S. population has at some point considered whether or not to 
circumcise a male infant. For many parents, this choice is dictated by religious traditions or 
cultural values, while for others personal preferences and family norms play a central role in the 
decision-making process. However, the circumcision decision also has potential health 
consequences for their infants. With this confluence of factors affecting a parent's decision to 
pursue this elective procedure, physicians are ethically obligated to consider the medical 
ramifications of the procedure and preferences of families as they counsel parents or make 
policy recommendations. 
One of the most frequently cited medical benefits of circumcision is a reduced frequency 
of UTis in childhood. Most UTis in males occur during the first year of life and many studies 
have found that uncircumcised males are at increased risk for UTI, especially during the first 
year of life 4 A recent systematic review of 12 studies on this topic concluded that circumcision 
appears to reduce a male's risk of UTI within the first 10 years of life from 1% to 0.13%.s 
Although this corresponds to a dramatic relative reduction, the baseline risk for UTI is low, even 
among the group at greatest risk (younger than one year of age). Given the 1% risk among 
normal boys for contracting a UTI, 111 boys would need to be circumcised to prevent one UTI. 
The literature on the connection between circumcision status and penile cancer is 
difficult to evaluate, but recent reviews indicate that uncircumcised men have a slightly higher 
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risk of developing penile cancer, probably due to increased rates of phimosis in this population, 
rather than human papillomavirus (HPV) infection?·9 Given the extremely low prevalence of 
penile cancer in the United States- estimated at 0.3-1.0 per 100,0009 - the implications of this 
risk increase are difficult to determine. However, considering the severity of this disease, any 
potential increase in risk may factor into some parents' decision-making processes. 
Circumcision has also been suggested to decrease the risks of contracting STis. A 2006 
meta-analysis confirmed that circumcised men are at significantly lower risks for syphilis and 
chancroid than uncircumcised men. 11 However, the substantial heterogeneity of included 
studies (e.g. study location, high-risk populations vs. low risk populations, methods for 
assessing circumcision status) limits the certainty of these findings, as well as their applicability 
for neonatal circumcision in the general U.S. population. Evidence for associations between 
circumcision and other STis is even less convincing. This same meta-analysis found no 
significant difference in the risk of genital herpes between circumcised and uncircumcised 
males, 11 and a more recent systematic review and meta-analysis established that 
uncircumcised men are no more likely to have gonorrhea or Chlamydia than their circumcised 
counterparts. 10 
Considerable research has also investigated the relationship between circumcision 
status and HIV infection. According to the American Academy of Pediatrics (AAP): 
There does appear to be a plausible biologic explanation for this association in that the mucous 
surface of the uncircumcised penis allows for viral attachment to lymphoid cells at or near the 
surface of the mucous membrane, as well as an increased likelihood of minor abrasions resulting 
in increased HIV access to target tissues 4 
A 2005 systematic review including 37 observational studies on HIV and male circumcision 
suggests that circumcision is associated with decreased rates of HIV acquisition within high-risk 
groups, but not among the general population-'" A 2009 systematic review by the same author 
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reports that there is strong evidence that circumcision dramatically reduces HIV acquisition in 
heterosexual men (38-66% reduction over two years). 12 This 2009 review differs from the 2005 
review in that it only analyzes the results of three recent randomized-controlled trials from Africa 
that investigated the protective effects of circumcision against HIV. 
These recent randomized-controlled trials of male circumcision for HIV prevention in 
Kenya, Uganda, and South Africa are seminal studies and have ignited considerable interest in 
whether circumcision in the U.S. could achieve similar reductions in risk of acquiring HIV and 
other sexually transmitted infections. The WHO now fully supports male circumcision as an 
"important strategy for the prevention of heterosexually acquired HIV infection in men,"29 
However, there is still uncertainty about how these results extrapolate to the U.S. population, 
especially given the differences in HIV epidemics and circumcision prevalence between African 
countries and the U.S. 
For example, in 2007, the prevalence of HIV (among adults 15-49 years-old) in South 
Africa, Kenya, and Uganda ranged from 5.4-18.1%, whereas HIV prevalence in the U.S. was 
0.6%. 30 Most sexual transmission of HIV in South Africa, Kenya, and Uganda occurs through 
male-female intercourse. In the United States, the majority of sexual transmission of HIV occurs 
among men who have sex with men (MSM) who represented 71% of H IV infections among 
adult and adolescent males in 2005. 31 In addition, the HIV serotypes differ by geographic 
location with certain viral types afflicting African populations and other types infecting people in 
the U.S. All of these differences could alter the effectiveness of circumcision for HIV prevention 
when translated to the U.S. Additionally, these studies do not resolve the uncertainty about the 
role of circumcision in preventing other STis. 
IV. SCIENTIFIC UNCERTAINTY ABOUT CIRCUMCISION AND STis 
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Associations between male circumcision and prevention of sexually transmitted 
infections (STis) are inconsistent in the medical literature. There are some negative studies, 
some positive studies, and some studies with methodological flaws that make their results 
uncertain. The lack of data establishing definitive and significant protective effects from 
circumcision, in combination with the low rates of complications for this neonatal procedure, has 
created a state of clinical equipoise surrounding this health-related decision. This is reflected in 
the American Academy of Pediatrics' current policy statement, written in 1999 and reaffirmed in 
2005, which states that there is insufficient scientific evidence to either recommend or 
discourage neonatal circumcision from a medical standpoint4 
In their 2005 policy reaffirmation, the AAP dedicates significantly more space to 
discussion of the relationship between circumcision and UTI risk than STI risk. This is likely due 
to the disparate states of evidence for UTis and STis at the time the AAP issued the policy 
statement when there was greater scientific consensus supporting the role of circumcision for 
decreasing UTI risk. They specifically state that, "Evidence regarding the relationship of 
circumcision to STD in general is complex and conflicting. "4 Given the considerable uncertainty 
of evidence when the previous AAP statement was issued, and in light of new evidence 
demonstrating the substantial preventive effects of circumcision after the newborn period, an 
up-to-date systematic evidence review on circumcision for STI prevention could help inform 
future recommendations about routine circumcision for preventive purposes. 
Thus, to direct medical guidelines and research we need a systematic review to address 




The focused question for this review is: Does the circumcision of newborn males in the 
U.S. prevent STis among adolescent and adult males? 
The uncertain role of circumcision in preventing STis deserves special attention because 
of the substantial burden of suffering imposed by a range of STis in the U.S. STis are far more 
common than the two other health outcomes commonly associated with circumcision status, 
male UTis and penile cancer. I decided to include a range of STis in this review. Different STis 
may serve as important outcomes because they are widespread (e.g. chlamydia, human 
papillomavirus), associated with substantial morbidity/mortality (e.g. syphilis, HIV), or both. In 
all instances, I plan to look at these outcomes as they occur among adolescents and adults 
because exposure to STis does not occur until after the onset of sexual activity. 
The STis addressed in this review include HIV, human papillomavirus (HPV), syphilis, 
chancroid, herpes simplex, chlamydia, gonorrhea, and hepatitis 8 and C. This list is based on 
the volume of studies published on specific infections found in a general background search of 
the literature on circumcision, specific outcomes examined in previous reviews, and burden of 
suffering (e.g. disease prevalence, morbidity, mortality) associated with specific diseases. To 
simplify analysis, these STis can be broken into subgroups including: 1 )Genital ulcerative 
diseases (syphilis, chancroid, herpes simplex); 2) Mucopurulent diseases (chlamydia, 
gonorrhea); and 3) Other viral STis (HIV, HPV). STis within these subgroups share certain 
characteristics including disease processes and symptoms. Disease outcomes within 
subgroups could be similarly affected by circumcision, which may influence interpretation of the 
results. Furthermore, these logical subgroups facilitate presentation of results. 
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ELIGIBILITY CRITERIA 
The eligibility criteria for studies in this systematic review are displayed in Table I and 
summarized here. Studies that met each of the following criteria were included in the review: 
(1) Targeted U.S. males as study population; (2) Included circumcision in the newborn period as 
the study intervention or exposure (if case-control studies); (3) Included detection of STI among 
adolescent and young adult males confirmed by laboratory and/or clinical diagnosis as the study 
outcome; (4) Study design was systematic review, randomized-controlled trial, non-randomized-
controlled trial, cohort study (retrospective and prospective), case-control study, or cross-
sectional study; and (5) Published after 1948. 
I excluded studies with international target populations and studies including 
circumcision outside of the newborn period from formal review. However, I kept these studies 
for reference (e.g. background, discussion). 
Table I. Eligibility Criteria* 
Selection Criteria Inclusion Exclusion 
Population - Males in the United States - International populations, 
women 
Intervention - Circumcision in newborn - Circumcision outside of 
period newborn period 
Comparison - Compared to no - Lack of comparison 
circumcision 
Outcome - Diagnosis of STI among - No STI confirmed 
adolescent and adult males - UTI pathogen 
confirmed by laboratory - Penile cancer 
diagnostics and/or clinical - Persistent infection 
diaQnosis 
Study design - Systematic reviews, - Case reports, case series 
RCTs, NRCTs, cohort 





*STI -sexually transmitted mfection; UTI - unnary tract mfectJon; RCT- randomized-controlled tnal; 
NRCT = non-randomized-controlled trial 
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To be included, studies needed to designate detection of STI among adolescent and adult 
males confirmed by laboratory and/or clinical diagnosis. Centers for Disease Control (CDC) 
surveillance data indicate that adolescents and young adults have the highest rate of STis 
compared with other age groups in the U.S-"2 I focused on this age range not only because of 
disease burden but also because I predicted that investigators would be unlikely to measure STI 
outcomes much later in adulthood for reasons of impracticality. 
SEARCH STRATEGY 
I searched MEDLINE, Cochrane Database, and EM BASE for relevant publications from 
1948 through April 2009. I consulted a health sciences librarian to assist the development of my 
search strategy. Using a combination of key words and Medical Subject Headings (MeSH 
terms) pertaining to male circumcision and STis, I identified relevant citations and stored them 
in an EndNote X2 database. The search terms used for each database search are displayed in 
Table 2. 
Table 2. Search strategy by database 
Database Search terms Result 
MEDLINE ("Human papillomavirus 6"[Mesh] OR "Human 572 
papillomavirus 16"[Mesh] OR "Human papillomavirus 
18"[Mesh] OR "Human papillomavirus 11 "[Mesh] OR 
"Syphilis"[Mesh] OR "Chancroid"[Mesh] OR "Herpes 
simplex"[Mesh] OR "Chlamydia trachomatis"[Mesh] OR 
"Gonorrhea"[Mesh] OR "HIV"[Mesh] OR "Hepatitis B"[Mesh] 
OR "Hepatitis C"[Mesh] OR "Sexually Transmitted 
Diseases"[Mesh]) AND "Circumcision, male"[Mesh] 
Cochrane ("Human papillomavirus 6"[Mesh] OR "Human -1 Cochrane 
Library papillomavirus 16"[Mesh] OR "Human papillomavirus review 
18"[Mesh] OR "Human papillomavirus 11 "[Mesh] OR -2 other 
"Syphilis"[Mesh] OR "Chancroid"[Mesh] OR "Herpes review 
simplex"[Mesh] OR "Chlamydia trachomatis"[Mesh] OR -15 clinical 
"Gonorrhea"[Mesh] OR "HIV"[Mesh] OR "Hepatitis B"[Mesh] trials 
OR "Hepatitis C"[Mesh] OR "Sexually Transmitted -4 economic 
Diseases"[Mesh]) AND "Circumcision, male"[Mesh] evaluations 
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EMBASE (("Human papillomavirus 6" or "Human papillomavirus 16" or 151 
"Human papillomavirus 18" or "Human papillomavirus 11" or 
"Syphilis" or "Chancroid" or "Herpes simplex" or "Chlamydia 
trachomatis" or "Gonorrhea" or "HIV" or "Hepatitis B" or 
"Hepatitis C" or "Sexually Transmitted Diseases") and 
"Circumcision").hw. 
After identifying and resolving areas of overlap between the searches above, I reviewed 
both abstracts and then full-text articles for eligibility. I checked the reference lists of included 
articles for additional relevant citations. 
QUALITY CRITERIA 
For assessing study quality (internal validity), I used the United States Preventive 
Services Task Force (USPSTF) methods. 33 I graded the internal validity of each study as 
"good," "fair," or "poor."33 The criteria used to assess individual studies (by design) and 
descriptions for the overall grade of internal validity are presented in Table 3 and Table 4. Due 
to the subjectivity of the grading scale, a more detailed description of a study's grade is included 
where necessary. 
Table 3. Quality criteria by study design 
Study design Criteria 
Systematic reviews - Search strategy; comprehensive list of 
sources 
- Assess publication bias 
- Appraisal of studies 
- Validity of conclusions 
- Timely, up-to-date, important 
- Assesses heterogeneity if meta-
analysis performed 
Case-control studies - Level of selection bias (accuracy of 
case ascertainment, appropriate 
control group that is chosen 
independently of circumcision status, 
eligibility criteria applied evenly, 
response rate) 
- Level of measurement bias (equal, 
reliable, valid) 




- Level of selection bias (comparability of 
groups if comparison done, eligibility 
criteria) 
- Level of measurement bias (equal, 
reliable, valid) 
- Confounding (confounders 
identified/measured/addressed) 
RCTs, NRCTs and cohort studies - Comparability of groups 
(randomization, concealment, 
restriction criteria, measurement of 
confounders) 
- Attrition, loss to f/u, crossover, 
adherence very large or differing by 
group 
- Measurement (equal, reliable, valid) 
- Intervention explicit 




. . .. 
-"" Adapted from USPSTF cntena for gradmg the internal validity of indiVIdual studies 
Table 4. Study_ ratings based on quality criteria 
Rating Appraisal criteria met 
Good Meets all criteria; very low potential for 
systematic bias 
Fair Does not meet all criteria, but does not have 
fatal flaw or bias that completely explains 
results 
Poor Has fatal flaw (e.g. results could be explained 
completely by bias, complete lack of 
information on important components of study 
design) 
* 
.. . _,, Adapted from USPSTF cntena for gradmg the internal validity of indiVIdual stud1es 
SELECTION OF ARTICLES 
Due to resource limitations, I conducted the steps involved in study selection 
independently. Ideally, I would have had two reviewers independently assess abstracts and full-
text articles. After conducting my search, I began the selection process with a review of 
relevant abstracts. I applied the eligibility criteria to titles and abstracts and discarded irrelevant 
studies (some were kept for background). Following abstract review, I applied the eligibility 
criteria to the full text of the remaining articles. I repeated both the abstract review and full-text 
review to ensure that no relevant studies were inappropriately excluded. 
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DATA ABSTRACTION 
In the next step, I abstracted evidence from included articles. Again, data extraction was 
performed independently without double review. I used a standardized abstraction form to 
collect data from each study, and the following characteristics were extracted from each study: 
date of data extraction; title; author(s); year of publication; journal; number of studies included in 
paper; year in which study was conducted; details regarding other relevant papers cited; 
study characteristics (population; care setting; methodological quality of the study; interventions; 
outcomes); outcome measures/results (length of follow-up; drop-outs/crossovers; missing 
data; discrete/continuous results; risk comparisons; and effect measures). 
Based on the information extracted from individual studies, I constructed a set of 
evidence tables to summarize my findings. Each table listed the included studies (author and 
year) as individual rows. Evidence tables included one descriptive table with information about 
study characteristics and basic design and another table with quality rating information. This 
table included information about potential for selection bias, measurement bias, confounding, 
analysis methods, external validity, and overall internal validity of the study. Finally, I developed 
a table dedicated to reporting important results, in the form of effect measures, from individual 
studies. 
I synthesized the information in these tables qualitatively. I considered breaking the 
studies down according to study quality or STI subgroup, but finally decided to stratify studies 
according to the risk profile of the study population (see Results below). I did not perform 





The literature search identified 745 potentially relevant citations. I modeled the search 
strategies used for EMBASE and the Cochrane Database after my MEDLINE search, using 
similar search terms, which resulted in duplicate citations. I excluded 75 duplicate citations prior 
to abstract review. Figure 1 shows the flow of my literature search starting with abstract review. 
Of the 670 abstracts reviewed, I excluded 628. I excluded 488 abstracts because they did not 
meet one or more eligibility criteria (see Figure 1). I excluded 68 abstracts that were relevant 
except that they were international studies. Another 72 abstracts failed to meet eligibility criteria 
but I kept them as useful background resources (e.g. commentaries on relevant articles, 
responses by authors of relevant articles, policy recommendations). 
I identified one additional relevant citation by hand searching the reference lists of the 
included abstracts, leaving a total of 43 citations for full-text review. At full-text review, I 
excluded 31 articles that did not meet one or more of the eligibility criteria (15 with wrong study 
population; five were not original research; two with wrong outcomes; one with wrong 
intervention; four with wrong study design; and four either lacked comparison group, were 
unable in full-text form, or had been updated by a more recent version). This selection process 
left me with 12 articles to include in the review26• 3444 
TYPES OF STUDIES RETRIEVED 
The 12 included articles described 13 observational studies (one article described both a 
cross-sectional and a cohort study). There were nine cross-sectional studies, one case-control 
study, and three cohort studies. No RCTs or systematic reviews were included (three African 
RCTs excluded at abstract review stage; seven systematic reviews excluded at full-text review 
stage because they included international studies). 
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Figure 1. Flow diagram of article selection 
Abstracts reviewed (n=670) 
Abstracts excluded and reasons 
(n=628) 
- Relevant international studies 
(n=68) 
- Useful background (n=72) 
- Irrelevant abstracts (n=488; 
letter/comment, news article, 
wrong outcome [e.g. penile 
cancer, UTI], wrong study type 
[e.g. case reports, narrative 
review], wrong intervention 
[e.g. female circumcision], 
wrong population [female risk 
for STI], no comparison group, 
not published in English) 
Hand searching citations of 
relevant full-text articles (n=1) 
Potentially relevant full-text 
articles reviewed (n=43) 
Full-text excluded and reasons 
(n=31) 
- Wrong population/setting 
(n=15; i.e. not at U.S. study) 
- Not original research (n=5; 
letter to editor, commentary) 
- Wrong outcome (n=2; e.g. 
bacterial vaginosis) 
- Wrong intervention (n=1; 
circumcision not considered) 
- Wrong design (n=4; e.g. 
narrative review) 
- Other (n=4; no comparison 
group, full-text unavailable) 
Relevant articles for abstraction 
and appraisal (n=12) 
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The studies meeting eligibility criteria assessed outcomes including gonorrhea, 
chlamydia, syphilis, HIV, genital herpes (or HSV-2 status), genital warts (or HPV status), 
chancroid, and hepatitis (unspecified type). Five studies (one cohort, one case-control, three 
cross-sectional) included multiple STI outcomes, with gonorrhea, chlamydia, and syphilis being 
the most commonly included. One cross-sectional study included all of the outcomes listed 
above (except chancroid and genital warts/HPV) and also had outcomes for "all bacterial" and 
"all viral" STis26 
The included studies investigated populations that differed in their risk profile for STis. 
Two studies examined the association between circumcision status and ST!s among males in 
the general U.S. population; seven others looked at high-risk heterosexual males at STD clinics; 
and four studied MSM in major U.S. cities. The studies, which were stratified by population risk 
profile, are described below and summarized in Tables 5 through 7 (Appendix A). 
CIRCUMCISION EFFECT AMONG GENERAL U.S. POPULATION 
Laumann and colleagues identified a nationally representative sample of 1,511 men 
between 18-59 years-old (with oversampling for African Americans and Hispanics) in the 
National Health and Social Life Survey (NHSLS)- 1992 and studied the association between 
circumcision status and an array of bacterial and viral ST!s, including: gonorrhea, syphilis, 
chlamydia, herpes, hepatitis (type unspecified), and HIV26 75% of the study population was 
circumcised. Investigators measured circumcision status by participant self-report and 
confirmed STI status by validated lab tests. The circumcision groups differed with respect to 
multiple characteristics (with many more unreported). Notably, circumcised men were more 
educated and less likely to be African American or Hispanic. In this cross-sectional study, they 
detected no association between circumcision status and any of the specified outcomes (see 
Table 7 for effect measures by outcome). 
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Using data from The National Health and Nutrition Examination Survey (NHANES), 
1999-2004, Xu and associates studied 4,185 boys and men (14-49 years old) to determine if an 
association exists between circumcision status and HSV-2 seropositivity.44 NHANES employed 
a nationally stratified, multistage probability design that oversampled for adolescents, blacks, 
and Mexican Americans. 79% of participants were circumcised. All participants identified 
circumcision status by self-report and underwent serologic testing for HSV-2. In the absence of 
randomization (cross-sectional design), groups had limited comparability: circumcised 
participants were younger, more likely to be foreign-born, less likely to be a minority, and had 
fewer lifetime sex partners compared to uncircumcised participants. Investigators found no 
association between being uncircumcised and HSV-2 seropositivity (adjusted OR [95% Cl] = 1.1 
[0.8-1.5]). 
Quality of the Studies and Summary of Findings 
Both of these cross-sectional studies assessing the association between circumcision 
status and STis in the general U.S. population were fair quality studies. For both studies, the 
circumcision groups being compared differed substantially due to lack of randomization, 
matching, or restriction. Although both studies measured numerous potential confounders and 
made appropriate adjustments in their logistic regression analysis, the results may be biased by 
unknown, unmeasured confounders and limited comparability of study groups. The use of self-
report for measuring circumcision status creates potential for misclassification bias in both 
studies. The possible non-differential misclassification bias in the study by Xu et al. may 
partially explain the null finding 44 Despite the moderate potential for bias in both studies, no 
systematic errors appear to seriously threaten the validity of their findings of no associations 
between circumcision status and numerous STI outcomes including gonorrhea, syphilis, 
chlamydia, HSV-2, hepatitis, and HIV. 
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CIRCUMCISION EFFECT AMONG HIGH-RISK HETEROSEXUAL MALES IN U.S. 
Using patients seen at U.S. Naval Hospital venereal clinics in St. Albans, NY, Hand 
compared 1,391 servicemen without STis to 1,082 servicemen with gonorrhea, 532 with 
syphilis, and 138 with chancroid in order to test for an association between circumcision status 
and ST1s.39 The control group was mostly white with a large proportion of Jewish men. The 
case groups had much higher proportions of blacks compared with the control group. Hand 
does not describe his methods of measurement or consider any potential confounders. His 
analysis is limited to descriptive frequencies of circumcision among the different groups. Using 
these frequencies, I calculated unadjusted ORs with 95% Cis for each outcome. Hand's 
findings suggest strong associations between being uncircumcised and having all three 
outcomes (gonorrhea- 6.05 [5.03-7.28]; syphilis- 5.47 [4.32- 6.92]; chancroid- 23.7 [11.5-
48.8]). 
Cook and coworkers reviewed the charts of 2, 776 heterosexual men, who sought care 
for a new problem at an STD clinic in Seattle, WA, to assess whether an association exists 
between circumcision status and multiple STI outcomes (gonorrhea, syphilis, chlamydia, genital 
herpes, and genital warts). The sample included 985 men without STis and 81% of the study 
population was circumcised. Circumcision status was measured by clinical exam at the time of 
the visit and all patients consenting for exam underwent STI testing. The comparability of 
circumcision groups by various cofactors was unreported. Investigators found lack of 
circumcision to be associated with gonorrhea, syphilis, and genital warts (adjusted ORs [95% 
Cl] = 1.6 [1.2-2.2], 4.0 [1.9-8.4], 0. 7 [0.5-0.9], respectively). The results suggest a trend toward 
protection by circumcision against gonorrhea and syphilis, but increased odds for genital warts. 
Diseker and colleagues used data from a randomized controlled trial of HIV prevention 
counseling, which took place in STD clinics in Baltimore, Denver, Long Beach, Newark, and San 
Francisco, to study the relationship between circumcision status and STis (gonorrhea, 
chlamydia, and syphilis} among 2,021 heterosexual men who came to STD clinics for an 
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exam. 37 834 of participants did not have the STis in question and 75% were circumcised. More 
than half of participants were African American. Investigators did not describe the comparability 
of circumcision groups. Circumcision status was measured by clinical exam and STI outcomes 
were lab-confirmed. 1,456 of2,021 participants followed up after baseline at 6 or 12 months, or 
both. The article includes both cross-sectional and cohort results, which were similar. Overall, 
the investigators found no association between circumcision status and STis except for a 
marginal finding from the cohort analysis suggesting an association between lack of 
circumcision and gonorrhea (adjusted OR [95% Cl] = 1.6 [1.0-2.6]). 
Baldwin and associates studied 443 high-risk men attending a public STD clinic in 
Tucson, AZ to test for an association between circumcision status and HPV status (any type, 
non-oncogenic, and oncogenic). 34 67% of participants were circumcised and 90% self-identified 
as heterosexual. Participants had a greater prevalence of multiple, concurrent STis compared 
to non-participants. Data on group comparability was not reported and HPV outcomes are 
missing for 50 men (mostly white and circumcised). Circumcision status determined by clinical 
exam and HPV detected by PCR followed by sub-typing. The investigators detected an 
association between circumcision and HPV status, suggesting protection by circumcision 
against any non-oncogenic, oncogenic, and any type of HPV {adjusted ORs [95% Cl] = 0.44 
[0.23-0.81], 0.44 [0.22-0.90], and 0.34 [0.20-0.57], respectively). 
Based on data from the same randomized controlled trial of HIV prevention counseling 
used by Diseker and colleagues37, Gottlieb and coworkers evaluated the relationship between 
circumcision and HSV-2 seropositivity among 1,120 heterosexual men attending STD clinics in 
five major U.S. cities (see list above). Participants were followed prospectively for 12 months. 
More than half the population was African American and 71% of participants were circumcised. 
All participants tested negative for HSV-2 at baseline. Circumcision groups were not 
comparable and the investigators report nothing about those lost to follow-up. They measured 
circumcision status by clinical exam and tested participants for HSV-2 seroconversion at 
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baseline and follow-up visits (6 and 12 months). After 12 months of follow-up, Gottlieb and 
coworkers found no relationship between circumcision status and HSV-2 seroconversion 
(adjusted hazard ratio [95% Cl]1.0 [0.6-1.6]). 
Warner and colleagues studied data from 40,571 STD clinic visits made by 26,448 
heterosexual African American men who underwent HIV testing at two STD clinics in Baltimore, 
MD in order to test for an association between circumcision and HIV status43 87% of clinic 
visits were made by circumcised men. Participants had no previous positive or uncertain HIV 
tests. 394 and 40,177 visits were made by men with known and unknown HIV exposure, 
respectively. Uncircumcised participants were older and had a higher proportion of STD (not 
HIV) diagnoses than circumcised men. Clinicians measured circumcision status by physical 
exam and determined HIV status by immunoassay screening and Western blot confirmation. 
Among men with known HIV exposure, investigators detected an association between 
circumcision and being HIV seropositive (adjusted OR= 0.49 [0.26-0.93]). However, findings 
from the group with unknown HIV exposure did not suggest a trend towards protection by 
circumcision (1.00 [0.86-1.15]). 
Quality of the Studies and Summary of Findings 
This group of articles focusing on high-risk heterosexual populations in the U.S. included 
two fair quality cohort studies,37• 38 one poor quality case-control study, 39 and four fair quality 
cross-sectional studies.34• 36• 37• 43 Both cohort studies had strong potential for selection bias due 
to limited comparability of circumcision groups (no randomization, matching, or restriction) and 
moderate potential for confounding resulting mainly frorn lack of randomization. The study by 
Diseker and colleagues had differential follow-up by circumcision status, which could bias 
results toward a protective circumcision effect and potentially explain some of their findings 
favoring circumcision (see Table 6). 37 Given the lack of reporting about participants reasons for 
not following up, there is significant uncertainty about the presence of such bias. 
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The case-control study by Hand (from 1949) was rated as poor primarily due to 
uncertain methodology. He does not state his technique for measuring exposure and 
outcomes. Cases and controls were significantly different according to reported cofactors like 
race and religion. His analysis did not include any calculation of effect measure. My 
calculations of unadjusted ORs do not account for any confounders. Thus, despite the 
apparently strong association between circumcision and three STis (gonorrhea, syphilis, and 
chancroid) detected by Hand, the study's results are not internally valid. 
All four cross-sectional studies have large potential for selection bias due to limited 
comparability of study groups. The study by Baldwin and associates found an association 
suggesting protection by circumcision against HPV, but their analysis did not adjust for 
education and socioeconomic status (SES). 34 Both education and SES are likely confounders, 
which could partially explain this study's results, although their findings are consistent for all 
HPV types and robust even after adjustment for other cofactors. Additionally, education and 
SES may also be confounders in the study by Warner and colleagues, whose findings suggest 
protection by circumcision against HIV among those with known HIV exposure43 These factors 
were not fully addressed and may partially explain their results, unless their study population 
was homogenous with respect to education and SES (distribution of these factors not reported). 
Only one out of seven studies of high-risk heterosexual males had fatal flaws-"9 This 
poor quality case-control study by Hand also found the strongest association between lack of 
circumcision and having STis (gonorrhea, chlamydia, and syphilis). One cohort study37 and 
three cross-sectional studies34• 36" 43 also had findings that suggested a protective effect by 
circumcision. The other cohort study"8 and cross-sectional study37 found no association 
between circumcision status and STis. Overall, these studies of circumcision among high-risk 
heterosexual males in the U.S. demonstrate mixed results. 
CIRCUMCISION EFFECT AMONG MSM IN MAJOR U.S. CITIES 
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Kreiss and Hopkins studied the relationship between circumcision and HIV serostatus 
among 502 MSM in Seattle, WA who were recruited at three study sites (two AIDS 
comprehensive care clinics and one public health screening center} 40 85% of participants were 
circumcised, 90% were white, and 316 were HIV seropositive. All the seronegative men were 
recruited at the screening center. Uncircumcised men were older, more often non-white, and 
more likely to have a history of syphilis. Patients self-reported circumcision status and HIV 
serostatus was measured by ELISA screening and Western blot confirmation. Investigators 
detected an association between lack of circumcision and being HIV seropositive (adjusted OR 
[95% Cl] = 2.0 [1.0-4.0]). 
Using data from the Vaccine Preparedness Study (VPS), an 18 month-long prospective 
cohort study in Boston, Chicago, Denver, New York, San Francisco, and Seattle, Buchbinder 
and associates tested for an association between circumcision status and HIV seroconversion 
among 3,257 high-risk MSM-"5 88% of participants were circumcised and 75% were white. 
Investigators did not report participant characteristics by circumcision status and 12% of 
participants did not complete the study. Circumcision status was measured by self-report and 
HIV seroconversion was lab confirmed (at 6, 12, and 18 months). The study revealed an 
association between lack of circumcision and HIV seroconversion after 18 months of follow-up 
(adjusted OR [95% Cl] = 2.0 [1.1-3.7]). 
Millet and coworkers evaluated the association between circumcision and HIV in a 
cross-sectional study of 1,154 black MSM (from New York and Philadelphia) and 1,081 Latino 
MSM (from New York and Los Angeles). 41 74% of black participants were circumcised 
compared to 33% of Latino participants. Investigators found participants through network-based 
recruiting. Among the black participants, circumcised MSM were older, more educated, and 
had unprotected anal sex with more partners. In the group of Latinos, circumcised MSM were 
more likely to be born in the U.S. Participants self-reported circumcision status and 
investigators screened for HIV by ELISA and patient history with confirmation by Western blot. 
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Neither black nor Latino MSM groups displayed an association between circumcision and HIV 
serostatus (adjusted ORs [95% Cl] = 1.23 [0.87-1.74] and 1.10 [0.73-1.66], respectively). 
Reisen and colleagues studied the association between circumcision and HIV status 
among 482 immigrant Latino MSM living in New York City (146 Brazilian, 169 Colombian, 167 
Dominican)42 25% of participants were circumcised and MSM in this population were burdened 
by a relatively high prevalence of STis. Circumcision and HIV status were both measured by 
self-report. Circumcised men reported higher education level and circumcision rate did not vary 
by country of origin. The investigators analyzed results for the whole sample and by country of 
origin. They detected an association between lack of circumcision and HIV seropositivity 
among the whole study population (adjusted OR [95% Cl] = 1.9 [1.01-3.59]). Analyses by 
country of origin showed the same association, but only among the Colombian group (adjusted 
OR [95% Cl] = 4.06 [1.40-11.75]). 
Quality of the studies and Summary of Findings 
The studies focusing on the urban MSM populations in the U.S. included one fair quality 
cohort study,35 two fair quality cross-sectional studies,41 • 42 and one poor quality cross-sectional 
study40 Potential selection bias due to poor comparability of circumcision groups limited the 
quality of all four studies. The cohort study by Buchbinder and associates does not have a 
specific bias that could explain their findings, which suggest a protective effect of circumcision 
against HIV. Both the fair quality cross-sectional studies have moderate potential for non-
differential misclassification bias, which could partially explain the null finding in the study by 
Millet and coworkers and cause an underestimation of the association detected by Reisen and 
colleagues (see Tables 6 and 7). The poor quality cross-sectional study, by Kreiss and 
Hopkins, failed to address important potential confounders like SES and education, which could 
bias their findings in favor of circumcision. This strong potential for confounding and selection 
bias severely limits the internal validity of the study. 
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Each of the four studies examining MSM populations focused on HIV status as their 
outcome. The one poor quality cross-sectional study'0 found an association suggesting a 
protective effect by circumcision. Two of the other three studies had findings that pointed to 
possible protection by circumcision,35•42 with the strongest evidence coming from the cohort 
study by Buchbinder and associates. Reisen and colleagues detected an association between 
lack of circumcision and self-reported HIV status, but this finding may be attributed to the sub-
group of Colombian men in their Latino study population. Overall, the studies among MSM in 
the U.S. reveal mixed results with regard to the effect of circumcision. 
DISCUSSION 
Whether circumcision reduces the risk for STis among adu~ men in the U.S. is 
controversial. The literature on this topic consists of studies that suggest protective, mixed, and 
harmful effects of circumcision. In this systematic review, I identified 13 U.S. observational 
studies that sought to elucidate the relationship between circumcision status and various STI 
outcomes. The populations investigated by these studies differed with respect to risk profile. 
Two studies assessed the general population of U.S. males and neither found an association 
between circumcision status and various STI outcomes. Seven studies focusing on high-risk 
heterosexual populations (at STD clinics in major U.S. cities) report mixed results for 
circumcision, with conflicting or null findings across an array of STI outcomes. The final four 
studies included urban MSM populations with HIV as their outcome of interest. These four 
studies presented protective and null findings, suggesting an uncertain effect of circumcision. 
Taken together, this evidence implies that circumcision does not uniformly reduce the risk for 
STis among adult men in the U.S. and that its effect is uncertain in both low risk and high risk 
populations. 
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OVERALL FINDINGS BY STI AND STI SUBGROUP 
To build a better understanding of the specific effects of circumcision, I looked for trends 
in the data according to individual STI and STI subgroups. Of the STI outcomes included, HIV 
had the most consistent relationship with circumcision status across studies. In four out of six 
studies with HIVoutcomes, investigators found a trend towards protection by circumcision. 35• 40• 
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43 Excluding the results from the one poor quality HIV study,40 studies that detected an 
association between circumcision and HIV reported that the odds of having HIV among 
uncircumcised men doubled the odds of having HIV among circumcised men (see Table 7). 
The overall evidence for HIV is muddled, however, by the poor quality study and two other 
studies that found no association26· 41 Furthermore, a study among Latino MSM suggested 
protection by circumcision,42 but additional analysis demonstrated that the finding was likely 
attributed only to the Colombian immigrant MSM in the study population, which confuses 
circumcision's effect among Latino MSM. 
Gonorrhea was a common outcome, appearing in five studies. One of these studies 
was a poor quality case-control study that demonstrated increased odds for gonorrhea among 
uncircumcised men relative to circumcised men, but was riddled with potential biases due to 
unclear methodology and limited analyses. 39 Two other studies suggested that the odds of 
having gonorrhea among uncircumcised men were one-and-a-half times greater than the odds 
among circumcised men.36• 37 One of these studies was a cohort analysis showing only a 
marginal association (95% Cl of 1.0-2.6) that did not match the null findings in the cross-
sectional analysis of the same population. Despite some evidence of protection against 
gonorrhea, inconsistent results and findings of no association make circumcision's effect less 
clear. 
Chlamydia, the other mucopurulent STI considered along with gonorrhea, was the 
outcome in four studies. None of these studies demonstrated a meaningful association 
between circumcision status and chlamydia. Of the ulcerative STis (syphilis, herpes, and 
28 
chancroid) only syphilis appeared to have any association with circumcision, showing a potential 
protective effect but only in one of four studies. 36 Of the remaining viral STis, only studies with 
HPV as an outcome found an association with circumcision. Results of the two HPV studies 
directly conflict, however, with an apparent protective effect of circumcision among the general 
population against clinically diagnosed genital warts but a harmful effect of circumcision among 
high-risk heterosexual men when the outcome was HPV detected by PCR.26· 34 Only one study 
looked at hepatitis as an outcome (without specifying type) and found no association26 
Overall, the evidence from this review does not suggest a consistently protective or 
harmful effect of circumcision. Although there were studies suggesting a protective effect 
against certain STis (HIV, gonorrhea), there were also several studies of the same STis 
reporting no benefit (i.e. no association). Thus, there is insufficient evidence to conclude that 
circumcision is or is not protective against STis in the U.S. 
OTHER RESEARCH 
Previous systematic reviews have assessed the potential protective effects of 
circumcision. Seven of these systematic reviews were included in the full-text review stage of 
this study, but were excluded from abstraction and appraisal because they reviewed both U.S. 
and international studies. Three of these studies considered multiple STI outcomes and four 
looked solely at HIV as an outcome. In 2007, Van Howe identified 30 articles to help determine 
the relationship of circumcision status to the risk for genital ulcerative disease (GUO) and 
sexually transmitted urethritis (caused by gonorrhea and chlamydia). 10 He included 
observational studies from across the globe and performed meta-analysis by STI subgroup 
despite the presence of significant qualitative heterogeneity between studies. Although he 
found that GUO had a trend towards being more common among uncircumcised men and that 
uncircumcised men were no more likely to have sexually transmitted urethritis than their 
circumcised counterparts, the heterogeneity (e.g. study location, exposure/outcomes 
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measurement, risk profile of population) between included studies brings significant uncertainty 
to the findings. 
In another review, Weiss and colleagues identified 26 articles (both U.S. and 
international observational studies) in order to assess the association between circumcision 
status and HSV-2, chancroid, and syphilis." Their findings suggested that male circumcision 
was associated with a reduced risk for syphilis and chancroid, but not HSV-2. Much like the 
study by Van Howe, the qualitative heterogeneity between studies assessed by Weiss and 
colleagues limits the sureness of these findings. 
To address the relationship between circumcision status and HIV as well as other STis 
among MSM, Millet and coworkers performed a systematic review with meta-analysis of 
available observational data from around the world 45 They included 18 observational studies 
and did not detect any statistically significant association between circumcision and HIV among 
all MSM nor among MSM engaging primarily in insertive anal sex. However, they did uncover a 
protective association between circumcision and HIV in MSM studies conducted prior to the 
highly active antiretroviral therapy (HAART) era, which was comparable to the protective effect 
observed in the three recent circumcision RCTs of African men46-48 
In a systematic review published earlier this year, Siegfried and associates evaluated 
three large circumcision RCTs of men from the general population in South Africa, Kenya, and 
Uganda.12· 46-48 These trials enrolled a combined 11,054 HIV negative men who were 
randomized to circumcision or control group and followed for up to 24 months. Together, these 
RCTs found that medical male circumcision reduced HIV incidence among heterosexual men by 
between 38% and 66%. In the review, they reported "low to moderate' potential for biases to 
explain the studies' results. Previous systematic reviews (2003 and 2005) by Siegfried and 
associates identified 35 and 37 observational studies, respectively, that tested the association 
between circumcision and HIV28• 49 Both of these prior reviews concluded that there was 
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insufficient evidence to definitively support the protective role of circumcision against HIV 
infection in heterosexual men28· 49 
Prior to the 2009 review by Siegfried and colleagues, the systematic reviews exploring 
the protective role of circumcision against STis included only observational data. With the 
exception of the three RCTs from Africa, the literature on this topic appears to echo the 
uncertainty regarding the risk-lowering role of circumcision against STis reported in this review. 
LIMITATIONS 
The evidence base described in this review has significant limitations. The only 
potentially relevant RCTs come from Africa and they were excluded from this review of U.S. 
studies. All 13 included studies had strong potential for selection bias due to limited 
comparability of groups, although it was unclear how this bias affected the results from each 
study. Investigators consistently attempted to account for unevenly distributed confounders 
through adjustment in multivariate analysis, but the confounding variables addressed often 
varied by study, which made comparisons between studies difficult. The methods for assessing 
circumcision status and measuring outcomes also differed by study with some investigators 
employing patient self-report and others using clinical exams and lab tests. None of the studies 
asked about the age at which participants were circumcised. 
This review also has limitations. I included cross-sectional studies because they 
represent the bulk of the evidence on the relationship between circumcision and STis in the 
U.S. These cross-sectional designs lacked randomization, matching, or restriction to ensure 
comparability of groups, which accounted for much of the potential selection bias. Additionally, 
the cross-sectional data can limit causal inference. Although in the case of circumcision in the 
U.S., it seems reasonable to assume that nearly all participants without foreskins underwent 
neonatal circumcision, which would have preceded any exposure to STis. Another important 
limitation to my study design was the lack of independent, dual review of abstracts and full-text 
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articles. In an attempt to redress this reliability issue, I repeated the abstract review and full-text 
reviews a second time one week after the initial review. Still, I may have inadvertently left out 
relevant studies. 
Another potential caveat of this review is the limitation to U.S. studies. This strategy was 
based on the fact that circumcision/ STI prevalence, transmission patterns, pathogen 
characteristics (e.g. HIV subtypes), and treatment for STis in the U.S. do not directly correspond 
to those seen internationally. Had I not restricted my review to the U.S., I could have included 
better quality studies from other countries, like the three African RCTs. But the differences 
listed above could alter the effectiveness of circumcision for STI prevention when translated to 
the U.S. Thus, I believe that limiting studies to the U.S. was a strength of this study and critical 
to answering the focused question. 
Finally, I did not attempt to pool data frorn included studies for meta-analysis. Although 
quantitative findings might have lent support to the conclusions of this review, there was far too 
much qualitative heterogeneity among the studies in question (e.g. study design, outcomes 
reported, exposure/outcome measurement). Meta-analysis would have been inappropriate and 
so its absence should not be considered a limitation. 
IMPLICATIONS FOR POLICY AND FUTURE RESEARCH 
This systematic review has important implications for clinicians, policymakers, and 
researchers. I developed my focused question because it addresses a potential preventive role 
for newborn circumcision --preventing STis later in life-- that is not yet fully understood 4 My 
findings here in this review should further convince stakeholders that the effect of circumcision 
on STI outcomes in the U.S. is still uncertain. Although the WHO supports male circumcision as 
an "important strategy for the prevention of heterosexually acquired HIV infection in men," this 
policy stance is heavily influenced by the findings from the African RCTs and the body of 
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evidence supporting the biologic plausibility of circumcision's protective effect against HIV4 • 29 
U.S. policies regarding circumcision should be informed by the new evidence from Africa as well 
as the findings from domestic, observational studies, which point to a need for more information 
before endorsing circumcision as a panacea against STis in the U.S. 
This review has highlighted the differential risk profiles in the U.S., and described the 
reported effects of circumcision in the general population, high-risk heterosexual male 
populations, and MSM populations. For policymakers like the AAP Task Force on Circumcision, 
the findings among the general male population, rather than those for high-risk populations 
(heterosexual men attending STI clinics, MSM), should be the most salient. Pediatricians will 
not know a child's future adult STI risk profile and cannot recommend circumcision based on 
risk level. A blanket policy statement promoting circumcision for prevention against STis should 
be based on evidence from the general population, because the policy would affect all males. 
After conducting this review, it is clear that the "evidence regarding the relationship of 
circumcision to STD in general is complex and conflicting."4 In future policy statements on 
circumcision, the AAP will hopefully continue to acknowledge and publicize the uncertain 
relationship between circumcision and STis in the U.S. Likewise, physicians should continue to 
consider all of the important medical and non-medical factors affecting a parents' decision to 
circumcise their child, and appropriately inform parents of the risks, benefits, and uncertainties 
of circumcision. 
Considerable gaps exist in the literature of male circumcision in the U.S. For example, 
certain outcomes like hepatitis B and Care Ullderrepresented. Additionally, there is a 
conspicuous absence of high-quality prospective studies with comparable groups and 
methodology that includes genital exams, diagnostic tests for STls, and appropriate multivariate 
analysis. Research may be more likely to advance among groups at high-risk for certain STis, 
like MSM. In their 2008 systematic review, Millet and colleagues make a strong case for a 
circumcision RCT for MSM.45 Although an RCT in any U.S. population would provide critical 
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advancement to the current state of evidence, there is limited feasibility for such a study in the 
U.S. The need for an RCT would need to outweigh recruitment challenges, logistical burden of 
adequate follow-up, and most importantly, the ethical dilemma posed by randomizing individuals 
(as adults or children) to be circumcised. 
CONCLUSIONS 
Using data from 13 observational studies, I attempted to answer the question, "Does the 
circumcision of newborn males in the U.S. prevent STis among adolescents and young adults?" 
The quality of evidence was fair and the overall findings pointed to an uncertain relationship 
between circumcision and numerous STis. Some evidence suggesting a protective effect of 
circumcision came from studies of HIV among MSM. Even these results, however, are limited 
by biases and conflicting results between studies. Thus, there is insufficient evidence to 
conclude whether circumcision does or does not protect against STis. Given the 
preponderance of cross-sectional studies, there is a need for more high-quality prospective 
studies among high-risk groups (heterosexual men at STD clinics and MSM) with comparable 
circumcision groups and methodology that includes genital exams, diagnostic tests for STis, 
and appropriate multivariate analysis. In the absence of high quality studies that suggest 
otherwise, important stakeholders like the AAP and clinicians should continue to acknowledge 
the uncertain relationship between circumcision and STis, and translate this knowledge 
appropriately in their policy statements and recommendations to patients. 
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APPENDIX A- Evidence Tables 
. --·- -· -~-- ---· .. -· ·- -· ·-· --·-· ·--·--
Author/Year Design Location* Study population* Intervention Outcomes* Notes 
/exposure 
Studies of General U.S. Population 
Laumann et Cross- United States 1,511 men between 18-59 Circumcision - Bacterial STis: - National probability sample 
al., 1997 sectional years-old gonorrhea, syphilis, with oversampling for African 
- 75% circumcised chlamydia, all Americans and Hispanics 
- Nationally representative bacterial - Did not exclude based on 
sample from National Health sexual orientation 
and Social Life Survey -Viral STis: 
(NHSLS)- 1992 herpes, hepatitis, 
- Excludes those living in HIV, all viral 
group quarters and non-
English speakers 
Xu et al., Cross- Mobile examination 4,185 boys/men (14-49 Circumcision Herpes simplex - Details of survey 
2007 sectional centers across the years old) selected for The type 2 (HSV-2) methodology published by 
United States National Health and Nutrition positive by serology National Center for Health 
Examination Survey Statistics 5° 
(NHANES), 1999-2004 
- National stratified, 
multistage probability 
sample with oversampling 
for adolescents, blacks, and 
Mexican Americans 
- Excludes non-civilians and 
institutionalized populations 
- 79% circumcised 
Studies of High-risk Heterosexual Males at STD Clinics 
Hand, 1949 Case-control St. Albans, NY- U.S. U.S. servicemen Circumcision Gonorrhea, - Control group mostly white 
Naval Hospital - 1391 without STis syphilis, chancroid (non-Jewish) and Jewish 
venereal clinics - 1082 with gonorrhea - Case groups with higher 
- 532 with syphilis proportion of blacks 
- 138 with chancroid - AQes not described 
Cook et al., Cross- Seattle, WA- King Heterosexual men seeking Circumcision Gonorrhea, -Youngest age group 13-19 y 
1994 sectional County Public Health care at STD clinic (n=2, 776) syphilis, chlamydia, - Participants visited clinic for 
STD Clinic at - 80.5% circumcised genital herpes, new problem in 1988, but did 
Harborview Medical - 985 men without STis genital warts not return (excluded if only 
Center presenting for HIV testing) 
Diseker et al., Cross- STD clinics in 5 U.S. 2,021 heterosexual men Circumcision Gonorrhea, -Investigators used data from 
2000 sectional cities (Baltimore, MD; who came to STD clinics for chlamydia, syphilis a randomized controlled trial of 
Denver, CO; Long an exam HIV prevention counseling 
Beach, CA; Newark, - 75% circumcised (Project RESPECT) 51 
39 
NJ; San Francisco, - 834 men without STis - Data from 1993-96 
CA) - >50% of population African - Performed cross-sectional 
American and cohort analyses (see 
- ;::15 years-old below) 
- Spoke English 
- Vaginal sex <30 days ago 
Cohort STD clinics in 5 U.S. 1 ,456 of 2,021 men in cross- Circumcision Gonorrhea, - Investigators used data from 
(12 month cities (Baltimore, MD; sectional study (see above) chlamydia, syphilis a randomized controlled trial of 
follow-up) Denver, CO; Long -Returned for follow-up (at 6 HIV prevention counseling 
Beach, CA; Newark, or 12 months or both) (Project RESPECT)51 
NJ; San Francisco, - STI lab results recorded - Data from 1993-96 
CA) - 76% circumcised - Performed cohort and cross-
- 855 men without STis sectional analyses (see above) 
- >50% African American 
Baldwin et al., Cross- Tucson, 1\Z. Public 443 high-risk rnen attending Circumcision Human - Data from 2000-01 
2004 sectional STD clinic STD clinic for any reason papillomavirus - Participants self-referred to 
- ;:: 18 years-old (mean age (HPV) positive by clinic 
of 30 years old) PCR (any type, - Greater prevalence of 
-Mostly white and Hispanic, non-oncogenic, and "several STDs" among study 
single rnen oncogenic) participants compared to those 
- 67% circumcised, 75% US choosing not to participate 
born, 90% heterosexual, 
50% soent time in jail 
Gottlieb et al., Cohort STD clinics in 5 U.S. 1,120 heterosexual men (at Circumcision Herpes simplex - Investigators used data from 
2004 (12 month cities (Baltimore, MD; least) who came to STD type 2 (HSV-2) a randomized controlled trial of 
follow-up) Denver, CO; Long clinics for an exam positive by serology HIV prevention counseling 
Beach, CA; Newark, - ;::14 years-old (median age (Project RESPECT)51 
NJ; San Francisco, of 25 years-old) - Data from 1993-96 
CA) - 71% circumcised 
- Vaginal intercourse in last 
3 months 
-No genital herpes (or HSV-
2 positive) at baseline 
- Baseline HSV-2 sample 
available 
- >50% African American 
Warner et al., Cross- Baltimore, MD two 40,571 STD clinic visits by Circumcision HIV positive by - Data from 1993-2000 
2009 sectional STD clinics 26,448 heterosexual, African serology (assessed 
American men who for those with 
underwent HIV testing known HIV 
-No IVDU; no sex with men; exposure and 
no previous positive or unknown HIV 
uncertain HIV test; no exposure) 
condom use 
40 
- 87% of visits made by 
circumcised men; 63% by 
men > 25 years-old 
- 394 and 40,177 visits by 
men with known and 
unknown HIV exposure, 
respectively 
Studies of MSM in Major U.S. Cities 
Kreiss and Cross- Seattle, WA- 502 MSM recruited to Circumcision HIV positive by -Data from 1989-91 
Hopkins, 1993 sectional Harborview Medical participate at three sites serology 
Center AIDS Clinic; - 85% circumcised 
University Hospital - 316 HIV-seropositive men 
Virology Clinic; Public -90% white 
Health AIDS - Mean age = 35 years-old 
Prevention Project 
Buchbinder et Cohort Boston, MA; Chicago, 3,257 high-risk MSM Circumcision HIV seroconversion - VPS by HIV Network for 
al., 2005 (18 month IL; Denver, CO; New enrolled in the Vaccine Prevention Trials; prospective 
follow-up) York, NY; San Preparedness Study (VPS) cohort study of high-risk MSM, 
Francisco, CA; in 6 major US cities (see women at high risk for HIV, 
Seattle, WA notes) and IVD users52 
- 88% of visits by - Data from 1995-97 
circumcised men 
- 75% white; mostly > 35 
years-old 
Millet et al., Cross- New York, NY; 1,154 black MSM from New Circumcision H IV positive by - Data from 2005-06 
2007 sectional Philadelphia, PA; Los York and Philadelphia; 1,081 serology 
Angeles, CA- Latino MSM from New York 
Makeshift study sites and Los Angeles 
at office buildings, - 74% of black MSM and 
community-based 33% Latino MSM 
organizations and circumcised 
health centers - >18 years old 
Reisen et al., Cross- New York, NY- site 482 immigrant Latino MSM Circumcision HIV positive by - Recruited through ads in 
2008 sectional not specified (not living in New York City (146 self-report Latino gay media and by word-
STD clinic) Brazilian, 169 Colombian, of-mouth 
167 Dominican) - Participants compensated 
- :: 18 years-old $50 for participation plus $15 
- 25% circumcised for transportation 
- High STI rates 
. STI =Sexually transmitted infection; STD = Sexually transmitted disease; IVDU =intravenous drug use; MSM = men who have sex with men 
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Table 6. Qualitv Raf •.. . .. ~- ....... A t of s· th D ·r ' .............................. ·~ ..... .............. .. ... . .... ............. . ....... 
Author Potential for Potential for Potential for Analysis Methods External validity Overall Notes 
/Year Selection Bias Measurement Confounding Assessment Internal 
Bias Validityt 
Studies of General U.S. Population 
Laumann et +++ ++ ++ Appropriate Good Fair - Potential for 
al., 1997 -Not all - Circumcision -No adjustment for - Sampling of a variety -Selection differential 
characteristics status and STI randomization significantly of demographics from bias is misclassification 
reported by status based - Measured and associated cofactors across U.S. biggest issue bias (those not 
circumcision group on self-report adjusted for in multivariate - Not a high-risk study (limited knowing 
- Circumcised men - Potential potential analysis (age, population comparabi- circumcision and 
with more educated differential confounders race/ethnicity, lity of groups STI status may 
parents misclassifica- (demographics, SES/education, and missing default to "yes" 
- Lower % of African tion bias (see sex behavior) religion, residence, data) response for 
Americans and notes) sexual attitudes,# of circumcision 
Hispanics -All sex partners) question AND 
circumcised participants assume no 
-Only 1,118 men had lab testing past/current STI, 
included in effect for outcomes if unsure) 
measure calculation 
Xu et al., +++ ++ ++ Appropriate Good Fair -335 men 
2007 -Limited - Circumcision -No adjustment for -Applies to very large -Selection excluded from 
comparability of status by self- randomization significantly segment of U.S. males bias biggest analysis; 
groups report (given -Measured associated cofactors - Results may not apply issue: limited participant details 
- Compared to visual aid; see confounders in multivariate directly to certain high- compara- not described 
circumcision group, notes) include age, analysis (age, risk groups with higher bility of - Possible non-
uncircumcised group - Cofactors race/ethnicity, race/ethnicity, age at HSV-2 incidence and groups and differential bias 
was older, had measured by age at first sex, # first sex, # of lifetime prevalence uncertain due to self-report 
greater % minorities, self-report in of lifetime sex sex partners, about of circumcision 
was more likely born computer partners, birthplace) missing data 
outside U.S., had module birthplace 
fewer lifetime sex - HSV-2 status 
partners by antibody 
- 8% of those testing (type-
examined/surveyed specific) 
have no HSV-2 result 
(see notes) 
Studies of Hi h-risk Heterosexual Males at STD Clinics 
Hand, 1949 +++ +++ +++ Limited; no analysis Poor Poor -Age at 
- Ethnicity distribution - Methods for - No confounders methods described - Generalizability limited - Large circumcision not 
uneven between measuring considered or because study potential for specified 
cases and controls exposure and accounted for in population multiple - Methods section 
42 
- No matching or outcome not analysis demographics poorly biases very limited 
measures of group explained described 
comparability - Likely limited to 
servicemen in STD 
clinics 
Cook et al., +++ ++ ++ Appropriate Poor Fair -Age at 
1994 - Participant - Exposure -No adjustment for - Applies best to -Selection circumcision not 
characteristics not measured by randomization significantly heterosexual men bias is specified 
reported by clinical exam - Measured and associated cofactors seeking care at STD biggest issue -All consenting 
circumcision group - STI outcome adjusted for in multivariate clinics in Seattle (high- (limited patients 
- Comparability of lab-confirmed potential analysis (age, race, risk, urban) comparabi- underwent lab 
groups unknown (genital warts confounders residence, # sex - Difficult to extrapolate lily of groups) testing for 
diagnosed (demographics, partners, other STis) to wider population, but outcomes listed 
clinically) sex behavior) important result for this (except genital 
-Data from high-risk group warts) 
chart review - Genital warts 
- No report of screening part of 
inter-reviewer standard physical 
reliability exam 
Diseker et +++ ++ ++ Appropriate Fair Fair -Potential 
al., 2000; - Participant - Exposure -No adjustment for - Multiple US cities -Selection differential 
Cross- characteristics not measured by randomization significantly included (geographic bias is misclassification 
sectional reported by clinical exam - Uncertain which associated cofactors variety) biggest issue bias if STI at 
circumcision group (see notes) potential in multivariate - Limited to urban areas (limited baseline (based 
- Comparability of - STI outcome confounders analysis, but list of - Source population is com para- on clinical exam) 
groups unknown lab-confirmed measured (at factors is limited (age, high-risk: heterosexual bility of makes clinician 
- Samples for least age, race/ethnicity, study men seeking care at groups) more likely to 
lab testing race/ethnicity, site) STD clinics -Possible classify as 
collected from study site, # of - Prevalence/incidence measure- uncircumcised 
all participants sex partners, and of STis in this group ment bias - Measurement 
- Unclear how new partners) higher than general (see notes) still better than 
confounders population self-report 
measured - Important for source 
population 
Diseker et +++ (see cross- ++ (see cross- ++ Appropriate Fair Fair - If men did not 
al., 2000; sectional study sectional study -No adjustment for - Multiple US cities -Same follow-up 
Cohort above) above) randomization significantly included (geographic selection bias because they 
- No reasons reported - Baseline STI - Uncertain which associated cofactors variety) issues as recovered, then 
for loss to follow-up status does not potential in multivariate - Limited to urban areas cross- differential follow-
(565 men) affect confounders analysis, but list of - Source population is sectional up (higher% 
- Slightly higher% exposure measured (at factors is limited (age, high-risk: heterosexual study (above) uncircumcised 
uncircumcised in measurement least age, race/ethnicity, study men seeking care at - Issue of not following up) 
group without follow- at follow-up race/ethnicity, site) STD clinics differential could bias results 
uo (see notes) (circumci~JC>!l_ ~J~_qy __ site, #of - Prevalence/incidence follow-up toward 
43 
status sex partners, and of STis in this group (see notes) circumcision 
constant) new partners) higher than general benefit 
population 
-Important for source 
population 
Baldwin et +++ + ++ Adjustment for Poor Fair - Hispanics and 
al.,2004 - Participant - Circumcision -No significantly - Very high-risk group -Selection those with lower 
characteristics not status by randomization associated cofactors even compared to bias is education status 
reported by clinical exam -50-item in multivariate others attending STD biggest issue more likely to be 
circumcision group by trained questionnaire analysis (sex clinic (non-participants) (limited circumcised and 
(nothing reported clinician gave fairly frequency, genital - Results meaningful for comparabi- at higher risk for 
about group - Validated 50- comprehensive warts, condom use this small, high-risk lity of groups) HPV infection. 
comparability) item list of cofactors past 3 months and group but not -No These cofactors 
- Missing data on 50 questionnaire (demographics, last anal sex, steady necessarily for lower adjustment could influence 
men (inadequate lab given by sexual history, partner) risk, general population for ethnicity the results with a 
sample); these men trained risky sex - Did not adjust for or education bias towards a 
were more likely to be interviewer practices, education level or (see notes) protective effect 
white and - HPV condom use, ethnicity despite of circumcision. 
circumcised detection by STis) being independent 
PCR risk factors for HPV 
-Testing of lab infection 
accuracy(-/+ 
controlsi 
Gottlieb et +++ ++ ++ Appropriate Fair Fair - Loss to follow-
al.,2004 - Participant - Exposure -No adjustment for - Multiple US cities -Selection up: Project 
characteristics not measured by randomization significantly included (geographic bias: limited RESPECT 
reported by clinical exam - Uncertain about associated cofactors variety) comparability included 2,365 
circumcision group (see notes) which potential in multivariate - Limited to urban areas of groups women and men. 
(nothing reported - STI outcome confounders analysis (race, age, - Source population is and uncertain 25% did not 
about group lab-confirmed assessed (at study site, HSV-1 high-risk: heterosexual loss to follow follow up 
I 
comparability) - Samples for least race, age, serostatus, and % men seeking care at up (gender break -
- 1,120 men followed- lab testing study site, HSV-1 condom use) STD clinics -Possible down unknown; 
up (6 and 12 months), collected from serostatus, and - Prevalence/incidence misclassifi- uncertain "n" ) 
but uncertain how all participants % condom use) of STis in this group cation bias - Misclassification 
many men at baseline - Unclear how higher than general (see notes) bias if herpes at 
(see notes) confounders population baseline 
measured - Important for source presentation 
population makes clinician 
more likely to 
classify as 
uncircumcised 
Warner et +++ ++ ++ Appropriate Limited Fair -Exposure: 
al.,2009 - Neither circumcision - Circumcision -No adjustment for -Heterosexual, urban - Potential for default is not to 
group has any IVDU, status by randomization measure_d_C()factors population selection bias check 
44 
sex with men, clinical exam (see notes) (age, STDs, visit - High-risk group even with uncircumcised 
previous positive or (check box in - Not addressed: year, study site) (especially HIV-exposed restriction box, so default is 
uncertain HIV test, chart; see SES/education, group) circumcised (non-
condom use (all notes) sex frequency - Does not generalize to differential 
important cofactors - Cofactors (with/without general population or misclassification) 
restricted from study) abstracted HIV+ partner), # MSM - Self-report may 
- Uncircumcised from charts of partners, HIV+ be inaccurate 
group older and has - HIV partner's stage (e.g. lying, poor 
greater % of other serostatus by -Addressed: recall) for 
STD diagnoses standard age, STDs, visit cofactors 
- Other demographics enzyme year, study site restricted from 
not reported by group immunoassay/ study; analysis 
Western blot does not adjust 
alqorithm for them 
Studies of MSM in Major U.S. Cities 
Kreiss and +++ ++ +++ Adjustment for Limited Poor - Possible that 
Hopkins, - Differences between - Circumcision -No significantly - Does not apply to -Strong recruitment 
1993 circumcision groups status and randomization associated cofactors heterosexual men in potential for varied by site 
- Uncircumcised men cofactors by -Not addressed: including age,# of U.S. selection bias - All seronegative 
older, more often self-report SES, education, partners, frequency of - Uncertain applicability (limited MSM from 
nonwhite, more likely - HIV age at first sex, unprotected anal sex to wider MSM comparability screening site 
to have syphilis serostatus by religion, travel to population in U.S. of groups) (not treatment 
history, less likely to chart review high-risk areas because limited to and sites), thus may 
have IVDU history (ELISA with - Addressed: predominantly white, confounding have fewer risk 
- 3 HIV+ men with Western blot age, race, IVDU, urban source population factors that are 
unknown circumcision confirmation) prostitute use, # also associated 
status - Uncertain if of sex partners, with circumcision 
- All seronegative serostatus unprotected sex, status (SES, 
men recruited at prior to study study site education) 
Prevention Project used, or if 
(see notes) some tested 
after enrolling 
Buchbinder +++ ++ ++ Comprehensive list of Limited Fair - Self-report of 
et al., 2005 -Tested many factors - Circumcision -No confounders - Most risk factors -Selection exposure raises 
associated with H IV status and randomization considered and assessed are very bias due to possibility of non-
seroconversion; cofactors by -Addressed: appropriate specific to high-risk lack of differential 
circumcision groups self-report (at age, race, SES, adjustment for MSM population comparability misclassification 
not designed to be each visit) education, self- significantly - Hard to generalize to and loss to bias (towards 
similar (participant - HIV perceived risk, # associated cofactors wider population follow-up null) 
characteristics not seroconversion partners, partner (age, education, without 
reported by group) lab-confirmed serostatus, drug insurance,# partners, explanation 
- 12% of population (tested at each use, symptoms, unprotected sex, 
did not finish (no visit: baseline, STis, sit-e STis, nitrite_inhalants, 
------ --
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explanation of 6 mo., 12 mo., drugs) 
missing values) 18 mo.) 
Millet et al., +++ ++ ++ Comprehensive list of Limited Fair 
2007 - Used network-based - Circumcision -No confounders - Source population -Large 
recruiting status and randomization considered and probably a growing potential for 
- Poor comparability cofactors by -Not addressed: appropriate population in urban selection bias 
of groups self-report partner HIV+ adjustment for areas (especially Latino -Non-
-Black MSM: - HIV status -Addressed: significantly group, due to differential 
circumcised older, screened by age, race, associated cofactors immigration) misclassifica-
more educated, had ELISNself- SES/education, (age, education, - May not extrapolate to tion bias 
more anal sex report and IVDU, drugs, age income, sexual white MSM and very (towards null) 
partners confirmed by at first sex, sex identity, site, place of difficult to extrapolate to 
-Latino MSM: Western blot with high risk birth, unprotected heterosexual men 
circumcised more - English and MSM, # partners, anal sex, sex 
likely born in U.S., Spanish condom use, position, STis) 
used drugs more surveys STis, study site, 
insurance, sexual 
identity 
Reisen et +++ ++ ++ Appropriate Limited Fair 
al., 2008 - Uncertainty about - Self-report for -No adjustment for - Very high-risk group of -Strong 
comparability of circumcision randomization significantly MSM (immigrants from potential for 
groups status, -Addressed: associated cofactors nations with high HIV selection bias 
- Circumcised men cofactors, and age, education, (age, income, seroprevalence and -Moderate 
more educated (other HIV status sex with high-risk education, history of high seroprevalence potential for 
factors not reported) -Worry about MSM, STis, sex work, syphilis, among peers in U.S.) non-
- Circumcision rate misclassifica- place of birth, receptive role in anal - Uncertain if applies differential 
did not vary by tion bias immigration age, sex) even to all Latinos misclassifica-
country of origin -Survey in role in anal sex because sub-group tion bias 
- Missing data for 55 English, -Not addressed: analysis showed 
MSM (did not answer Spanish, drug use, travel protective effect only for 
HIV status question); Portuguese to country of Colombian group 
excluded from origin, partner 
analysis serostatus 
*STI = Sexually transmitted infection; STD = Sexually transmitted disease; IVDU = intravenous drug use; MSM = men who have sex with men 
tDefinition of internal validity (quality rating), see Table 4 
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Table 7. 0 
- ~-- II Studv R It .......... __ - _ ............ ~ ... 
Author/Year Results (effect measure)t Precision (95% Cl) Statistical Notes 
significance* 
Studies of General U.S. Population 
Laumann et Adjusted OR II NR - No association detected between circumcision status 
al., 1997 - Gonorrhea: 1.42 - Gonorrhea (0. 79 - 2.56) and specified outcomes 
- Syphilis: 2.14 - Syphilis (0.41, 11.30) - Fair quality study 
- Chlamydia: NR -Chlamydia (NR) - Moderate potential for bias but uncertain how this 
- All bacterial: 1.61 -All bacterial (0.94,2.78) affects results (e.g. misclassification bias could be 
- Herpes: 1.18 -Herpes (0.23,5.94) differential or non-differential) 
- Hepatitis: 1.22 - Hepatitis (0.43,3.46) 
- HIV: NR - HIV (NR) 
- All viral: 1.30 - All viral (0.52,3.2~ 
Xu et al., Adjusted OR:j: - No association between circumcision status and 
2007 - HSV-2 positive: 1.1 - HSV-2 positive (0.8 - 1.5) p = 0.47 being HSV-2 seropositive 
- Null finding could be partially explained by potential 
non-differential misclassification bias due to self-report 
of circumcision 
Studies of High-risk Heterosexual Males at STD Clinics 
Hand, 1949 Unadjusted OR:j:§ NR - Unadjusted ORs and Cis not reported in article, but 
- Gonorrhea: 6.05 -Gonorrhea (5.03- 7.28)§ calculated according to reported frequencies 
- Syphilis: 5.4 7 -Syphilis (4.32- 6.92)§ - Strong association for all three outcomes 
- Chancroid 23.7 -Chancroid (11.5- 48.8)§ -Wide Cl for chancroid (small sample size) 
- Suggest protective trend for circumcision against all 
three STI outcomes 
- Results questionable given strong potential for bias 
and unclear methodology 
Cook et al., Adjusted OR:j: NR - Association detected between circumcision status 
1994 - Gonorrhea: 1.6 -Gonorrhea (1.2- 2.2) and gonorrhea, syphilis, genital warts 
- Syphilis: 4.0 -Syphilis (1.9- 8.4) - Protective trend for circumcision against gonorrhea 
- Chlamydia: 1.0 -Chlamydia (0.7 -1.6) and syphilis (limited precision for syphilis result) 
- Genital herpes: 1.2 -Genital herpes (0.8 -1.7) - Protective trend for lack of circumcision against 
-
Genital warts: 0. 7 -Genital warts (0.5- 0.9) genital warts 
- No association between circumcision status and 
chlamydia or genital herpes 
- Fair quality study that does not display definitive 
benefit of circumcision 
Diseker et al., Adjusted OR:j: NR - No association detected between circumcision status 
2000; Cross- - Gonorrhea: 1.3 - Gonorrhea (0.9 - 1. 7) and specified outcomes 
sectional - Syphilis: 1.4 -Syphilis (0.6- 3.3) -Fair quality study 
- Chlamydia: 1.0 -Chlamydia (0.7 -1.4) - Large potential but uncertain role of selection bias 
- Results could be biased slig_ht)y_ aw"!Y_from null leY_ 
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potential differential misclassification bias (above) 
Diseker et al., Adjusted OR:j: NR - Marginal finding of association between circumcision 
2000;Cohort - Gonorrhea: 1.6 -Gonorrhea (1.0- 2.6) status and gonorrhea 
- Syphilis: 1.5 -Syphilis (0.4- 6.1) - Only result differing from cross-sectional study from 
- Chlamydia: 0.9 - Chlamydia (0.5- 1.5) same source population 
- Bias introduced through differential follow-up could 
explain tendency toward protective effect of 
circumcision 
- Overall results suggest uncertain effect of 
circumcision 
Baldwin et al., Adjusted OR_Il. NR - Associations detected between circumcision status 
2004 - Any type HPV: 0.337 -Any type HPV (0.20- 0.57) and all three HPV outcomes 
- Non-oncogenic: 0.44 -Non-oncogenic (0.23- 0.81) - Results suggest protective trend of circumcision 
- Oncogenic: 0.44 - Oncogenic (0.22 - 0.90) against HPV infection (similar magnitude of effect for 
non-oncogenic, oncogenic, and any type HPV) 
- Consistent with results from international studies53' 54 
- Education and ethnicity are both likely confounders 
that may at least partially explain the results. Thus, it is 
possible that true effect is not as dramatic, although 
the results are consistent across outcome and robust 
after other adjustment in analysis 
Gottlieb et al., Adjusted HRt11 NR - No association between circumcision status and 
2004 - HSV-2 positive: 1.0 - HSV-2 positive (0.6- 1.6) becoming HSV-2 seropositive over 12 months 
-Few studies look at HSV-2 as outcome 
- Some uncertainty about result given uncertainty 
about group without follow-up and potential 
misclassiftcation bias away from null (toward protective 
effect of circumcision, see Table 6) 
Warner et al., Adjusted OR,II_ NR - No association between circumcision status and 
2009 - HIV+ (with known exposure): 0.49 -Known exposure (0.26 - 0.93) being HIV seropositive among men with unknown 
- HIV+ (with unknown exposure): 1.00 -Unknown exposure (0.86- exposure (larger segment of population) 
1.15) - Association detected between circumcision status 
and being HIV seropositive among men with known 
exposure 
- Suggests protective trend for circumcision against 
being HIV seropositive among men with known 
exposure 
-Applies only to those with known exposure (very high-
risk group) 
- Education and SES are both likely confounders that 
may at least partially explain the results. Thus, it is 
possible that true effect is not as dramatic, although 
their may be homogeneity in this population with 
regard to education/SES 
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Studies of MSM in MajorU.S. Cities 
Kreiss and Adjusted OR:j: NR - Association detected between circumcision status 
Hopkins, 1993 - HIV+: 2.0 -(1.0-4.0) and being HIV seropositive among this group of MSM 
-Suggests protective trend against being HIV 
seropositive among MSM attending these clinics in 
Seattle 
- Differences between groups by study site a major 
concern (differential recruitment, confounders) 
-Adjusted OR (95% Cl) of3.2 (0.9-11.7) when limiting 
to Prevention Project (screening site) 
-Association no longer statistically significant and Cl 
verv wide when limitino to this much smaller sample 
Buchbinder et Adjusted OR:j: NR - Association detected between circumcision status 
al., 2005 - HIV seroconversion: 2.0 - (1.1-3.7) and HIV seroconversion after 18 months among this 
group of high-risk MSM 
-Suggests protective trend against HIV seroconversion 
after 18 months 
-Of factors tested for association, circumcision had 
second lowest PAR% (1 0.2)t; large number of male 
sex partners, nitrite inhalant use, and younger age all 
with higher PAR %(28.3- 30.8) 
Millet et al., Adjusted 0~1,1 NR - No association detected between circumcision status 
2007 - HIV+ (Black MSM): 1.23 -Black MSM (0.87 -1.74) and being HIV seropositive among black or Latino 
-
HIV+ (Latino MSM): 1.10 -Latino MSM (0.73 -1.66) MSM 
-Authors suggest greater background HIV prevalence 
in this high-risk groups could diminish any protective 
effect 
- Non-differential misclassification bias could partially 
explain null finding 
Reisen et al., Adjusted OR:j: NR - Association detected between circumcision status 
2008 - HIV+ (whole sample): 1.9 -Whole sample (1.01 - 3.59) and being HIV seropositive among the whole sample 
- HIV+ (Colombians) 4.06 - Colombians (1.40- 11. 75) and the Colombian sub-group 
- HIV+ (Brazilians): 1.27 -Brazilians (0.35- 4.65) - Absence of association for Brazilian and Dominicans 
-
HIV+ (Dominicans): 0.84 -Dominicans (0.25- 2.89) could mean that Colombian group responsible for 
overall association for the whole sample 
- Uncertain if sub-group size large enough to detect 
meaninaful associations 
. NR =not reported 
tOR =odds-ratio; HR =hazard ratio; PAR % =population attributable risk percentage 
:j: Estimated ratio of odds of uncircumcised men having experienced the outcome relative to odds for circumcised men 
~ Effect measure not reported in study; calculated based on reported frequencies 
II Estimated ratio of odds of circumcised men having experienced specified outcome relative to odds for uncircumcised men 
,-r Ratio of incidence of outcome among circumcised men relative to incidence in uncircumcised men 
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